302 related articles for article (PubMed ID: 35659359)
21. Expression of carbonic anhydrase IX (CAIX) in malignant mesothelioma. An immunohistochemical and immunocytochemical study.
Capkova L; Koubkova L; Kodet R
Neoplasma; 2014; 61(2):161-9. PubMed ID: 24471939
[TBL] [Abstract][Full Text] [Related]
22. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
[TBL] [Abstract][Full Text] [Related]
23. The Relationship Between the Tumor Cell Expression of Hypoxic Markers and Survival in Patients With ER-positive Invasive Ductal Breast Cancer.
Shamis SAK; Quinn J; Mallon EEA; Edwards J; McMillan DC
J Histochem Cytochem; 2022 Jul; 70(7):479-494. PubMed ID: 35792080
[TBL] [Abstract][Full Text] [Related]
24. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion.
Robertson N; Potter C; Harris AL
Cancer Res; 2004 Sep; 64(17):6160-5. PubMed ID: 15342400
[TBL] [Abstract][Full Text] [Related]
25. UFH-001 cells: A novel triple negative, CAIX-positive, human breast cancer model system.
Chen Z; Ai L; Mboge MY; McKenna R; Frost CJ; Heldermon CD; Frost SC
Cancer Biol Ther; 2018 Jul; 19(7):598-608. PubMed ID: 29561695
[TBL] [Abstract][Full Text] [Related]
26. Carbonic anhydrase IX-related tumoral hypoxia predicts worse prognosis in breast cancer: A systematic review and meta-analysis.
Numprasit W; Yangngam S; Prasopsiri J; Quinn JA; Edwards J; Thuwajit C
Front Med (Lausanne); 2023; 10():1087270. PubMed ID: 37007798
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
[TBL] [Abstract][Full Text] [Related]
28. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
[TBL] [Abstract][Full Text] [Related]
29. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
Generali D; Fox SB; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield SM; Bruzzi P; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Bottini A; Harris AL
Endocr Relat Cancer; 2006 Sep; 13(3):921-30. PubMed ID: 16954440
[TBL] [Abstract][Full Text] [Related]
30. CAIX-Mediated Control of LIN28/
Gibadulinova A; Bullova P; Strnad H; Pohlodek K; Jurkovicova D; Takacova M; Pastorekova S; Svastova E
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560271
[TBL] [Abstract][Full Text] [Related]
31. The prognostic impact of a combined carbonic anhydrase IX and Ki67 signature in oral squamous cell carcinoma.
Klimowicz AC; Bose P; Petrillo SK; Magliocco AM; Dort JC; Brockton NT
Br J Cancer; 2013 Oct; 109(7):1859-66. PubMed ID: 24008660
[TBL] [Abstract][Full Text] [Related]
32. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
[TBL] [Abstract][Full Text] [Related]
33. Cellular and radiobiological effects of carbonic anhydrase IX in human breast cancer cells.
Güttler A; Theuerkorn K; Riemann A; Wichmann H; Kessler J; Thews O; Bache M; Vordermark D
Oncol Rep; 2019 Apr; 41(4):2585-2594. PubMed ID: 30720123
[TBL] [Abstract][Full Text] [Related]
34. Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer.
Kock L; Mahner S; Choschzick M; Eulenburg C; Milde-Langosch K; Schwarz J; Jaenicke F; Müller V; Woelber L
Int J Gynecol Cancer; 2011 Jan; 21(1):141-8. PubMed ID: 21330838
[TBL] [Abstract][Full Text] [Related]
35. Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis.
Chen Y; Li X; Wu S; Xu G; Zhou Y; Gong L; Li Z; Yang D
Med Oncol; 2014 Dec; 31(12):304. PubMed ID: 25377659
[TBL] [Abstract][Full Text] [Related]
36. CAIX furthers tumour progression in the hypoxic tumour microenvironment of esophageal carcinoma and is a possible therapeutic target.
Drenckhan A; Freytag M; Supuran CT; Sauter G; Izbicki JR; Gros SJ
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1024-1033. PubMed ID: 29865880
[TBL] [Abstract][Full Text] [Related]
37. Role of hypoxia and EGF on expression, activity, localization and phosphorylation of carbonic anhydrase IX in MDA-MB-231 breast cancer cells.
Li Y; Wang H; Tu C; Shiverick KT; Silverman DN; Frost SC
Biochim Biophys Acta; 2011 Jan; 1813(1):159-67. PubMed ID: 20920536
[TBL] [Abstract][Full Text] [Related]
38. Catalysis and pH control by membrane-associated carbonic anhydrase IX in MDA-MB-231 breast cancer cells.
Li Y; Tu C; Wang H; Silverman DN; Frost SC
J Biol Chem; 2011 May; 286(18):15789-96. PubMed ID: 21454639
[TBL] [Abstract][Full Text] [Related]
39. Metabolism-related proteins are differentially expressed according to the molecular subtype of invasive breast cancer defined by surrogate immunohistochemistry.
Choi J; Jung WH; Koo JS
Pathobiology; 2013; 80(1):41-52. PubMed ID: 22832328
[TBL] [Abstract][Full Text] [Related]
40. The hypoxia marker CAIX is prognostic in the UK phase III VorteX-Biobank cohort: an important resource for translational research in soft tissue sarcoma.
Forker L; Gaunt P; Sioletic S; Shenjere P; Potter R; Roberts D; Irlam J; Valentine H; Hughes D; Hughes A; Billingham L; Grimer R; Seddon B; Choudhury A; Robinson M; West CML
Br J Cancer; 2018 Mar; 118(5):698-704. PubMed ID: 29235571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
